BACKGROUND: Hematopoietic stem cells are retained within discrete bone marrow niches through the effects of cell adhesion molecules and chemokine gradients. However, a small proportion of hematopoietic stem cells can also be found trafficking in the peripheral blood. During induced stem cell mobilization a proteolytic microenvironment is generated, but whether proteases are also involved in physiological trafficking of hematopoietic stem cells is not known. In the present study we examined the expression, secretion and function of the cysteine protease cathepsin X by cells of the human bone marrow. DESIGN AND METHODS: Human osteoblasts, bone marrow stromal cells and hematopoietic stem and progenitor cells were analyzed for the secretion of cathepsin X by western blotting, active site labeling, immunofluorescence staining and activity assays. A possible involvement of cathepsin X in cell adhesion and CXCL-12-mediated cell migration was studied in functional assays. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) analysis revealed the digestion mechanism of CXCL-12 by cathepsin X. RESULTS: Osteoblasts and stromal cells secrete cathepsin X, whereas hematopoietic stem and progenitor cells do not. Using a cathepsin X-selective substrate, we detected the catalytic activity of cathepsin X in cell culture supernatants of osteoblasts. Activated cathepsin X is able to reduce cellular adhesive interactions between CD34(+) hematopoietic stem and progenitor cells and adherent osteoblasts. The chemokine CXCL-12, a highly potent chemoattractant for hematopoietic stem cells secreted by osteoblasts, is readily digested by cathepsin X. CONCLUSIONS: The exo-peptidase cathepsin X has been identified as a new member of the group of CXCL-12-degrading enzymes secreted by non-hematopoietic bone marrow cells. Functional data indicate that cathepsin X can influence hematopoietic stem and progenitor cell trafficking in the bone marrow.
BACKGROUND: Hematopoietic stem cells are retained within discrete bone marrow niches through the effects of cell adhesion molecules and chemokine gradients. However, a small proportion of hematopoietic stem cells can also be found trafficking in the peripheral blood. During induced stem cell mobilization a proteolytic microenvironment is generated, but whether proteases are also involved in physiological trafficking of hematopoietic stem cells is not known. In the present study we examined the expression, secretion and function of the cysteine protease cathepsin X by cells of the human bone marrow. DESIGN AND METHODS: Human osteoblasts, bone marrow stromal cells and hematopoietic stem and progenitor cells were analyzed for the secretion of cathepsin X by western blotting, active site labeling, immunofluorescence staining and activity assays. A possible involvement of cathepsin X in cell adhesion and CXCL-12-mediated cell migration was studied in functional assays. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) analysis revealed the digestion mechanism of CXCL-12 by cathepsin X. RESULTS: Osteoblasts and stromal cells secrete cathepsin X, whereas hematopoietic stem and progenitor cells do not. Using a cathepsin X-selective substrate, we detected the catalytic activity of cathepsin X in cell culture supernatants of osteoblasts. Activated cathepsin X is able to reduce cellular adhesive interactions between CD34(+) hematopoietic stem and progenitor cells and adherent osteoblasts. The chemokine CXCL-12, a highly potent chemoattractant for hematopoietic stem cells secreted by osteoblasts, is readily digested by cathepsin X. CONCLUSIONS: The exo-peptidase cathepsin X has been identified as a new member of the group of CXCL-12-degrading enzymes secreted by non-hematopoietic bone marrow cells. Functional data indicate that cathepsin X can influence hematopoietic stem and progenitor cell trafficking in the bone marrow.
Authors: A M Lambeir; P Proost; C Durinx; G Bal; K Senten; K Augustyns; S Scharpé; J Van Damme; I De Meester Journal: J Biol Chem Date: 2001-06-04 Impact factor: 5.157
Authors: G A McQuibban; G S Butler; J H Gong; L Bendall; C Power; I Clark-Lewis; C M Overall Journal: J Biol Chem Date: 2001-09-24 Impact factor: 5.157
Authors: Jerica Rozman Pungercar; Dejan Caglic; Mohammed Sajid; Marko Dolinar; Olga Vasiljeva; Urska Pozgan; Dusan Turk; Matthew Bogyo; Vito Turk; Boris Turk Journal: FEBS J Date: 2009-02 Impact factor: 5.542
Authors: Cristina Lo Celso; Heather E Fleming; Juwell W Wu; Cher X Zhao; Sam Miake-Lye; Joji Fujisaki; Daniel Côté; David W Rowe; Charles P Lin; David T Scadden Journal: Nature Date: 2008-12-03 Impact factor: 49.962
Authors: Nicole D Staudt; Andreas Maurer; Bärbel Spring; Hubert Kalbacher; Wilhelm K Aicher; Gerd Klein Journal: Stem Cells Dev Date: 2012-01-04 Impact factor: 3.272
Authors: Leah A Marquez-Curtis; A Robert Turner; Santhi Sridharan; Mariusz Z Ratajczak; Anna Janowska-Wieczorek Journal: Stem Cell Rev Rep Date: 2011-09 Impact factor: 5.739
Authors: Carolin Steinl; Mike Essl; Thomas D Schreiber; Konstanze Geiger; Lea Prokop; Stefan Stevanović; Oliver Pötz; Harald Abele; Johannes T Wessels; Wilhelm K Aicher; Gerd Klein Journal: Stem Cells Dev Date: 2013-02-12 Impact factor: 3.272
Authors: Rudolf Richter; Andrea Jochheim-Richter; Felicia Ciuculescu; Katarina Kollar; Erhard Seifried; Ulf Forssmann; Dennis Verzijl; Martine J Smit; Xavier Blanchet; Philipp von Hundelshausen; Christian Weber; Wolf-Georg Forssmann; Reinhard Henschler Journal: Stem Cells Dev Date: 2014-05-27 Impact factor: 3.272
Authors: Simon J Mountford; Bethany M Anderson; Bangyan Xu; Elean S V Tay; Monika Szabo; My-Linh Hoang; Jiayin Diao; Luigi Aurelio; Rhiannon I Campden; Erik Lindström; Erica K Sloan; Robin M Yates; Nigel W Bunnett; Philip E Thompson; Laura E Edgington-Mitchell Journal: ACS Chem Biol Date: 2020-02-14 Impact factor: 5.100